Gastroenterology Education and CPD for trainees and specialists » HBV Drugs Cut Risk of Cancer Recurrence (CME/CE)

- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

HBV Drugs Cut Risk of Cancer Recurrence (CME/CE)

BOSTON (MedPage Today) — Antiviral therapy after surgery appears to reduce the risk of recurrence of hepatocellular carcinoma related to hepatitis B, a researcher reported here.

Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com